A phase 1b dose escalation study of ipafricept (OMP[sbnd]54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

Autor: Moore, Kathleen N., Gunderson, Camille C., Sabbatini, Paul, McMeekin, D. Scott, Mantia-Smaldone, Gina, Burger, Robert A., Morgan, Mark A., Kapoun, Ann M., Brachmann, Rainer Karl, Stagg, Robert, Farooki, Azeez, O'Cearbhaill, Roisin E.
Zdroj: In Gynecologic Oncology August 2019 154(2):294-301
Databáze: ScienceDirect
Externí odkaz: